Aadi Enters into Exclusive License for Three-Asset ADC Portfolio Developed through a Collaboration between WuXi Biologics and HANGZHOU DAC Each of the three ADC assets utilizes HANGZHOU DAC's ...
The antibody-drug conjugate (ADC) manufacturing landscape offers the potential to leverage significant opportunities for cancer treatment, but faces complex challenges. Nevertheless, the ADC market ...
PMCC_XCM_64x64_D IP block is a low-power array of 1GHz clocked Cross-Correlator cells that are synchronously acquiring two sets of 64x2-bit data streams which are derived by digitizing IF signals at a ...
Abstract: The increased usage of wireless services in the congested electromagnetic spectrum has caused communication systems to contend with the existing operational radar frequency bands. Integrated ...
The Peoples Redemption Party (PRP) and the African Democratic Congress (ADC) have announced a potential merger aimed at addressing Nigeria’s most pressing issues, including the decline of ...
SHILLONG, Dec 11: The Opposition Trinamool Congress (TMC) appears unlikely to contest the upcoming Autonomous District Council (ADC) elections in Khasi and Jaintia Hills, citing a lack of interest ...
Daiichi will invest 1.1 billion Chinese yuan ($152 million) to build a new antibody-drug conjugate (ADC) manufacturing facility in Shanghai, the Japanese pharma said (Chinese), on the heels of ...
Zilovertamab vedotin is an ROR1-targeting antibody-drug conjugate (ADC) with a monomethyl auristatin E (MMAE) payload. The standard of care in this setting has historically been the R-CHOP regimen ...
The “scientific trailblazer” behind Daiichi Sankyo’s blockbuster ADC medicines, Toshinori Agatsuma, has passed away, the company said Monday.
Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate (ADC), trumpeting a 100% complete response rate but also reporting safety signals that informed the decision to take the ...